These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7692558)

  • 1. Is the selective non-peptide NK-1 receptor antagonist CP96,345 a peripherally acting analgesic?
    Berge OG; Ståhlberg M
    Regul Pept; 1993 Jul; 46(1-2):430-2. PubMed ID: 7692558
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist.
    Nagahisa A; Kanai Y; Suga O; Taniguchi K; Tsuchiya M; Lowe JA; Hess HJ
    Regul Pept; 1993 Jul; 46(1-2):440-3. PubMed ID: 7692561
    [No Abstract]   [Full Text] [Related]  

  • 3. Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580.
    Saria A; Troger J; Zernig G
    Regul Pept; 1993 Jul; 46(1-2):346-8. PubMed ID: 7692533
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
    Chahl LA; Johnston PA
    Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction.
    Yamamoto T; Yaksh TL
    Life Sci; 1991; 49(26):1955-63. PubMed ID: 1721102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of sensory response of the carotid body to hypoxia by NK-1 receptor antagonist CP-96,345.
    Prabhakar NR; Snider RM; Lowe JA; Cao H
    Regul Pept; 1993 Jul; 46(1-2):266-8. PubMed ID: 7692512
    [No Abstract]   [Full Text] [Related]  

  • 8. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Ohba M; Kisara K; Terenius L
    Regul Pept; 1993 Jul; 46(1-2):326-8. PubMed ID: 7692527
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
    Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H
    Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum.
    Turvill JL; Connor P; Farthing MJ
    Gastroenterology; 2000 Oct; 119(4):1037-44. PubMed ID: 11040190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociception induced by CP 96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests.
    Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Kisara K
    Neurosci Lett; 1993 Mar; 151(2):142-5. PubMed ID: 7685073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.
    Nicolau M; Sirois MG; Bui M; Plante GE; Sirois P; Regoli D
    Can J Physiol Pharmacol; 1993; 71(3-4):217-21. PubMed ID: 7691388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation.
    Nagahisa A; Asai R; Kanai Y; Murase A; Tsuchiya-Nakagaki M; Nakagaki T; Shieh TC; Taniguchi K
    Regul Pept; 1993 Jul; 46(1-2):433-6. PubMed ID: 7692559
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
    Rupniak NM; Carlson EC; Harrison T; Oates B; Seward E; Owen S; de Felipe C; Hunt S; Wheeldon A
    Neuropharmacology; 2000 Jun; 39(8):1413-21. PubMed ID: 10818257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
    Lau HY; Bhatia M
    J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of substance P and neurokinin-1 receptors in the responses of rat dorsal horn neurons to noxious but not to innocuous mechanical stimuli applied to the knee joint.
    Neugebauer V; Schaible HG; Weiretter F; Freudenberger U
    Brain Res; 1994 Dec; 666(2):207-15. PubMed ID: 7533634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
    Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist--a putative role for substance P in CNS inflammation.
    Nessler S; Stadelmann C; Bittner A; Schlegel K; Gronen F; Brueck W; Hemmer B; Sommer N
    J Neuroimmunol; 2006 Oct; 179(1-2):1-8. PubMed ID: 16904192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint.
    Neugebauer V; Weiretter F; Schaible HG
    J Neurophysiol; 1995 Apr; 73(4):1574-83. PubMed ID: 7643168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin receptors in the guinea pig ileum.
    Nguyen-Le XK; Nguyen QT; Gobeil F; Jukic D; Chrétien L; Regoli D
    Pharmacology; 1996 Jan; 52(1):35-45. PubMed ID: 8966201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.